A novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which caused a large respiratory outbreak in Wuhan, China in December 2019, is currently …

The distribution of the severe acute respiratory syndrome coronavirus (SARS-CoV) receptor,
an angiotensin-converting enzyme 2 (ACE2), does not strictly correlate with SARS-CoV cell …

The type II transmembrane protease TMPRSS2 activates the spike (S) protein of severe
acute respiratory syndrome coronavirus (SARS-CoV) on the cell surface following receptor …

The Middle East respiratory syndrome coronavirus (MERS-CoV) utilizes host proteases for
virus entry into lung cells. In the current study, Vero cells constitutively expressing type II …

During the emergence of novel coronavirus 2019 (nCoV) outbreak in Wuhan city, China at
the end of 2019, there was movement of many airline travelers between Wuhan and Japan, …

Here, we screened steroid compounds to obtain a drug expected to block host inflammatory
responses and Middle East respiratory syndrome coronavirus (MERS-CoV) replication. …

In cultured cells, SARS-CoV-2 infects cells via multiple pathways using different host
proteases. Recent studies have shown that the furin and TMPRSS2 (furin/TMPRSS2)-dependent …

Human coronaviruses (HCoVs) enter cells via two distinct pathways: the endosomal pathway
using cathepsins to activate spike protein and the cell-surface or early endosome pathway …

Proteolytic cleavage of the hemagglutinin (HA) protein is essential for influenza A virus (IAV)
to acquire infectivity. This process is mediated by a host cell protease(s) in vivo. The type II …

Steroid compounds, which are expected to have dual functions in blocking host inflammation
and MERS-CoV replication, were screened from a chemical library. Within this library, …